Neuphoria Therapeutics Inc (NEUP) support and resistance · rev $15.7M
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
This page maps Neuphoria Therapeutics Inc (NEUP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
NEUP currently screens at market cap $23.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NEUP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NEUP quote page for the session range and the stock page for the full model.
Not investment advice.